BLACK WEEKSFlakonai −15% · rinkiniai −10% · kita −5%su koduNemokamas siuntimas Vokietijoje nuo €200

Šis puslapis išverstas automatiškai ir jame gali būti klaidų. Ar lietuvių kalba yra jūsų gimtoji? Mielai sulauksime jūsų atsiliepimų ir pataisymų.Siųsti atsiliepimą

The Peptide Desk The Peptide Desk
Cabergoline, produkto nuotrauka
PCT & AI

Cabergoline

PCT & AI

  • Siunčiame iš Vokietijos

Užsakymas

Vieneto kaina - Nemokamas siuntimas Vokietijoje nuo 200 € Black Weeks metu
  • DHL su sekimu
  • Diskreti pakuotė

4.6 iš 5 TrustpilotAtsiliepimų: 73

Taip pat ieškoma kaip: Cabergolin

Trumpai

Cabergoline skaičiais

Pagrindiniai rodikliai iš mūsų žinyno. Vilkite tašką kreive, kad pamatytumėte, kiek lieka po vienos dozės, pagal skaičiavimą.

Visas žinyno įrašas

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~2.9 days

Half-life ~2.9 days
After 5.8 days: 25 %
Day 2.950 %Day 5.825 %Day 8.812.4 %Day 14.63.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about70hours

Class
Dopamine D2 receptor agonist
Use
Oral1-2x per week
Sizes
0.25 to 0.5 mg2 sizes in the shop

Produktui Cabergoline laboratorinės analizės dar nėra. Balsuoti už taiUžsakykite tyrimą, mes apmokame pusęVisos laboratorinės analizės

Žinios

Viskas apie Cabergoline

FAQ

Dažnai užduodami klausimai

Šaltiniai kiekvienam atsakymui: žinyno įrašas

Dar turite klausimų?

Parašykite mums, mūsų komanda jums padės.

How does cabergoline lower prolactin?

Cabergoline binds as an agonist to the dopamine D2 receptor. Dopamine is the natural brake on the prolactin cells in the pituitary. According to the label it has only low affinity for other receptors such as D1, alpha adrenoceptors and serotonin receptors.

Is cabergoline approved?

Yes. ChEMBL lists cabergoline as an approved compound with first approval in 1996. On ClinicalTrials.gov 83 trials list cabergoline (as of 26 October 2026). Everything here is the state of research, not a recommendation.

Is it better than bromocriptine?

In the large comparison trial with 459 women yes: prolactin was stably normal in 83 instead of 59 percent, 72 instead of 52 percent ovulated or became pregnant. Side effects occurred in 68 instead of 78 percent, 3 instead of 12 percent stopped. A French trial with 120 women came to the same result.

What about the heart valves?

The label requires a heart ultrasound before starting and checks every 6 to 12 months. Valve changes occurred mostly at high doses in Parkinson's treatment, but there are also cases at lower doses. In a cohort study in Parkinson's the rate was 68 per 10,000 person-years, with other drugs 10 to 11.

Why dizziness on standing?

Cabergoline can lower blood pressure, especially when standing up quickly. In the placebo-controlled trial 15 percent had dizziness and 4 percent a drop in blood pressure on standing, 5 and 0 percent on placebo. The label advises checking blood pressure at the start and during use.

Can cabergoline affect behaviour?

Yes, the label lists impulse control disorders: new or stronger urges to gamble, increased sexual urges, uncontrolled spending and binge eating. Anyone noticing this should raise it with a doctor.

Which trials are running right now?

As of 26 October 2026 recruiting trials include a phase 3 trial with 382 planned participants against bromocriptine, a phase 3 trial on the safety of a higher dose in microprolactinomas and a phase 4 trial on metabolism in prolactinomas.

Susiję

Susiję produktai